= Solution
\b[<p53> prevents stressed or potentially dangerous cells from expanding by coordinating repair, arrest, senescence and, when appropriate, cell death.] The normal <p53> <protein> is a sequence-specific <transcription factor> encoded by <TP53>. Its low unstressed abundance is maintained partly by <MDM2>-dependent ubiquitination and degradation. <DNA> damage, oncogene-associated stress and other perturbations can stabilize and activate it through signalling that modifies <p53>, its regulators and their interactions. <p53> also induces <MDM2>, forming a negative-feedback loop that allows recovery when the initiating stress resolves.
One outcome is reversible <cell-cycle arrest>. <p53> induces <p21>, a cyclin-dependent-kinase inhibitor, reducing kinase activity and helping retain <RB> control over <E2F>-dependent cell-cycle entry. This gives cells time to repair damage before <DNA> replication or division distributes errors. A pause itself is not <DNA> repair: repair enzymes must still remove lesions, and the cell must reassess whether proliferation can safely resume. Time-resolved measurements of <p53>, <p21> and cell-cycle progression therefore distinguish a protective transient response from a permanent arrest.
Severe or persistent stress can favour <apoptosis>. p53-dependent expression of <PUMA>, <NOXA> and <BAX> can shift the balance of BCL-2-family activities towards mitochondrial outer-membrane permeabilization and caspase activation. Removing a damaged cell prevents transmission of its mutations, but costs that cell to the tissue. Alternatively, <cellular senescence> produces a durable arrest that blocks immediate clonal expansion. The associated secretory phenotype can recruit immune responses, yet can also alter neighbouring tissue in harmful ways. Neither apoptosis nor senescence is an inevitable consequence of every increase in <p53>; duration, dose, cell type and survival signals shape the outcome.
<p53> also coordinates aspects of metabolism, redox control and maintenance of genome integrity. These functions can support survival during manageable stress and suppress conditions that favour transformation. It would therefore be misleading to identify normal <p53> solely as a death trigger or to assume that all its anticancer effects require an acute DNA-damage checkpoint. The barrier is layered: limiting mutation accumulation, preventing inappropriate proliferation, and eliminating or durably restraining cells that have acquired dangerous changes.
Genetic evidence establishes causality. Mice lacking <p53> were viable in the reported experimental population but highly susceptible to spontaneous tumours, showing that loss of its normal activity can promote tumorigenesis without requiring a special oncogenic mutant <protein>.<Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours by L. A. Donehower and others>[Donehower and colleagues, 1992, abstract and spontaneous-tumour observations]{ref} The experiment does not establish that <p53> has no developmental function in every genetic background. Human inherited TP53 predisposition and recurrent somatic TP53 alterations provide complementary evidence; different missense mutants can lose normal transcriptional function, inhibit remaining wild-type subunits or acquire context-dependent new activities.
To dissect the mechanism, compare matched p53-proficient, deficient and restored cells, then perturb individual targets such as <p21> or apoptotic effectors. Measure damage, proliferation, survival and long-term tumour formation separately, because reduced short-term viability is not equivalent to tumour suppression. \b[<p53> is a stress-responsive governor of cell fate whose tumour-suppressive value comes from preserving safe proliferation and preventing unsafe clonal expansion.]
Back to article page
